Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.